- /
- Supported exchanges
- / US
- / LFMD.NASDAQ
LifeMD Inc (LFMD NASDAQ) stock market data APIs
LifeMD Inc Financial Data Overview
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LifeMD Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get LifeMD Inc data using free add-ons & libraries
Get LifeMD Inc Fundamental Data
LifeMD Inc Fundamental data includes:
- Net Revenue: 250 M
- EBITDA: -1 362 313
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-17
- EPS/Forecast: -0.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LifeMD Inc News
New
Novo Nordisk (CPSE:NOVO B) Is Up 12.7% After Nationwide Launch Of Oral Wegovy Pill
Novo Nordisk has now launched the FDA-approved Wegovy oral GLP-1 pill across more than 70,000 U.S. pharmacies and telehealth channels, offering a once-daily option for chronic weight management and ca...
Why LifeMD (LFMD) Is Up 15.2% After Securing Credit Line And Adding Oral Wegovy Access
LifeMD recently entered into a senior secured revolving credit facility of up to US$50 million with Citizens Bank, maturing in 2029, while also expanding its telehealth obesity offerings by adding acc...
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks were lower late Monday afternoon, with the NYSE Health Care Index easing 0.1% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Novo Nordisk Rolls Out Wegovy's Weight Loss Pill in US
Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.